In this article you will find an overview of 5LO and FLAP, discussing their involvement in biochemical pathways relevant to AD pathogenesis and how targeting these proteins could lead to therapies relevant not only for AD, but also other related neurodegenerative conditions (Joshi and Pratico). Here, ALOX5AP is linked to Alzheimer disease.